Platelet-rich plasma injection for knee injury after a torn ACL, looking at later arthritis
Tests platelet-rich plasma injections in people with a recent anterior cruciate ligament knee injury.
Key facts
- Who runs it
- Hospital for Special Surgery, New York
- Where
- New York, United StatesSee the site
- Trial code
- Registry title
- PRP in ACLR to Prevent PTOA
- Status
- Recruiting
- Phase
- Phase 3
- People taking part
- 56 people, planned
- Started
- 27 Jun 2022
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- platelet rich plasma (PRP) injection
- placebo saline injection
- Record updated
- 13 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people aged 14 to 50 with a recent ACL (front knee ligament) tear. They will have ACL reconstruction surgery and get either PRP or salt-water placebo injections.
- Age
- 14 to 50 years
- Sex
- Male or female
- Disease stage
- Acute ACL injury within 6 weeks of presentation. A meniscus injury that can be treated by removal or repair is allowed. People without a meniscus injury can also join.
- Earlier treatment
- Cannot join after prior ACL reconstruction or cartilage repair, meniscus surgery within 12 months, or steroid, hyaluronic acid or PRP injection within 6 months.
Main reasons for not taking part
- Other ligament injury that needs repair
- Any cartilage damage that needs repair, or cartilage damage greater than grade 2 (partial thickness injury)
- History of inflammatory arthritis or joint infection (sepsis)
- Prior ACL reconstruction, cartilage repair, or meniscus surgery within 12 months
- Does not speak English
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Acute ACL injury within 6 weeks of presentation
- Age 14-50
- Male or female
- Meniscus injury that can be treated with meniscectomy or repair (the lack of meniscus injury will not exclude patients)
Who cannot take part
- Prior ACL reconstruction
- Prior cartilage repair procedure
- Prior meniscus surgery within 12 months
- Prior steroid, hyaluronic acid, or PRP injection within 6 months
- History of inflammatory arthritis or joint sepsis
- Other ligament injury requiring repair
- Any cartilage lesion requiring repair
- Any cartilage lesion greater than grade 2 (partial thickness injury)
- Non English speakers
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 14 and 50 years old?
Where in United States
- Hospital for Special SurgeryNew York, United StatesContact: Jessica Andres-Bergos, PhDTaking people
About the trial
What the trial wants to find out
The purpose of our study is to examine the effect of platelet-rich-plasma (PRP) injection on the short-term resolution of post-injury inflammation (biomarkers) and improvement in joint function in patients with acute ACL injury. This RCT has been powered based on the questionnaire KOOS Jr. but it is considered a 'pilot study' in terms of the lab analysis proposed.
The 2 groups in the trial
- Control ArmPlacebo, for comparison
The control arm will receive a pre-op placebo injection of saline, and ACLR surgery with intra-op placebo injection
Treatment: placebo saline injection
- Investigational ArmTreatment being tested
The investigational arm will receive a pre-op PRP injection, and ACLR surgery with PRP injection
Treatment: platelet rich plasma (PRP) injection
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Platelet Rich Plasma (PRP) Treatment of the Anterior Cruciate Ligament Injured Knee to Decrease the Risk of Post-traumatic Osteoarthritis (PTOA): a Randomized Double-blind Controlled Trial
- Plain-language title
- Platelet-rich plasma injection for knee injury after a torn ACL, looking at later arthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT05412381, who can take part
- Record updated
- 13 February 2026